Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityConstruction in ProgressConvertible DebtCurrent AssetsCurrent Deferred RevenueCurrent LeasesFinished GoodsGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLiabilities from Discontinued OperationsLong-Term Deferred TaxLong-Term InvestmentsNon-Current AssetsNon-Current Deferred Tax LiabilityNon-Current Deffered RevenueOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Raw MaterialsReceivablesRetained EarningsShareholder's EquityShares OutstandingShort-term InvestmentsTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current LiabilitiesTreasury SharesWork In Process
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Standard Biotools (LAB) Total Liabilities (2016 - 2025)

Standard Biotools (LAB) has disclosed Total Liabilities for 16 consecutive years, with $140.0 million as the latest value for Q3 2025.

  • On a quarterly basis, Total Liabilities fell 27.17% to $140.0 million in Q3 2025 year-over-year; TTM through Sep 2025 was $140.0 million, a 27.17% decrease, with the full-year FY2024 number at $140.6 million, down 12.04% from a year prior.
  • Total Liabilities was $140.0 million for Q3 2025 at Standard Biotools, up from $132.4 million in the prior quarter.
  • In the past five years, Total Liabilities ranged from a high of $469.2 million in Q2 2023 to a low of $125.0 million in Q1 2025.
  • A 5-year average of $186.6 million and a median of $167.3 million in 2022 define the central range for Total Liabilities.
  • Peak YoY movement for Total Liabilities: surged 180.42% in 2023, then tumbled 57.7% in 2024.
  • Standard Biotools' Total Liabilities stood at $180.6 million in 2021, then fell by 11.13% to $160.5 million in 2022, then fell by 0.41% to $159.9 million in 2023, then dropped by 12.04% to $140.6 million in 2024, then fell by 0.46% to $140.0 million in 2025.
  • Per Business Quant, the three most recent readings for LAB's Total Liabilities are $140.0 million (Q3 2025), $132.4 million (Q2 2025), and $125.0 million (Q1 2025).